Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001209191-19-058549

Chief Medical Officer acquired 46,202 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Londei Marco · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-27 Exercise or conversion : show line 1 in the form +46,202 $6.93 $320,180 68,579 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-11-27 Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) −46,202 4,946 D
Loading xslF345X03/doc4.xml…